Back to the complete issue
Wednesday, 3 February 2021

Rameda throws its hat in the ring for GSK’s Egypt business

Ladies and gentlemen, we have a good, old-fashioned bidding war: Rameda Pharma is the latest to show interest in GlaxoSmithKline’s Egypt business, joining LSE-listed Hikma Pharma and pharma industry investor Acdima — who are both planning their own bids. The company has submitted a non-binding letter of interest to GSK and is asking the multinational pharma giant for the green light to start due diligence, Rameda said in an EGX filing (pdf) yesterday.

BACKGROUND- The race began last week, when GSK said that it had signed a non-binding agreement with Hikma ahead of a potential sale of the British pharma major’s 91.2% stake in the Egypt commercialization and manufacturing business. Both Rameda and Acdima plan to target the same stake through a tender offer.

Are you advising one of the parties? Let us know on editorial@enterprise.press.

IN OTHER M&A NEWS-

Hong Kong-based Zeta Investments has submitted an offer to purchase 90% of brokerage house Alexandria National Company for Financial Investments (ANFI) at EGP 5.51 per share, according to disclosures from shareholders El Kahera El Watania Investment (KWIN) (pdf) and Abu Dhabi Islamic Bank (ADIB) (pdf).

Who owns what? KWIN currently owns some 40% of ANFI’s shares, while ADIB directly holds 9%. The Gulf lender has a total indirect stake amounting to 84.99%, due to owning a 74.75% stake in KWIN (pdf) and its subsidiary, ADI Lease, holding a 34.99% stake.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Etisalat Misr (tax ID: 235-071-579), the leading telecoms provider in Egypt; and Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt.